CRISM Therapeutics (CRTX) Competitors GBX 10.23 -0.77 (-7.00%) As of 07:45 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CRTX vs. ARCM, PREM, CLA, POW, KDNC, TUN, LND, BZT, ARV, and CDLShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Arc Minerals (ARCM), Premier African Minerals (PREM), Celsius Resources (CLA), Power Metal Resources (POW), Cadence Minerals (KDNC), Tungsten West (TUN), Landore Resources (LND), Bezant Resources (BZT), Artemis Resources (ARV), and Cloudbreak Discovery (CDL). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. Its Competitors Arc Minerals Premier African Minerals Celsius Resources Power Metal Resources Cadence Minerals Tungsten West Landore Resources Bezant Resources Artemis Resources Cloudbreak Discovery Arc Minerals (LON:ARCM) and CRISM Therapeutics (LON:CRTX) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Does the media favor ARCM or CRTX? In the previous week, Arc Minerals' average media sentiment score of 0.00 equaled CRISM Therapeutics'average media sentiment score. Company Overall Sentiment Arc Minerals Neutral CRISM Therapeutics Neutral Which has more volatility & risk, ARCM or CRTX? Arc Minerals has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500. Comparatively, CRISM Therapeutics has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Which has higher valuation & earnings, ARCM or CRTX? Arc Minerals has higher earnings, but lower revenue than CRISM Therapeutics. Arc Minerals is trading at a lower price-to-earnings ratio than CRISM Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArc MineralsN/AN/A£9.42M-£0.00-716.67CRISM Therapeutics£25K163.52-£792.20K-£0.04-232.50 Is ARCM or CRTX more profitable? Arc Minerals' return on equity of 71.86% beat CRISM Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Arc MineralsN/A 71.86% -5.85% CRISM Therapeutics N/A -13.12%-26.77% Do insiders & institutionals hold more shares of ARCM or CRTX? 3.2% of Arc Minerals shares are held by institutional investors. Comparatively, 0.3% of CRISM Therapeutics shares are held by institutional investors. 13.7% of Arc Minerals shares are held by insiders. Comparatively, 97.3% of CRISM Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryArc Minerals beats CRISM Therapeutics on 5 of the 9 factors compared between the two stocks. Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£4.09M£1.10B£3.71B£2.58BDividend YieldN/A6.09%5.07%5.32%P/E Ratio-232.50134.04156.624,378.48Price / Sales163.5257,144.9427,003.14101,221.76Price / CashN/A24.7024.3227.90Price / Book0.249.227.277.94Net Income-£792.20K£71.69M£148.99M£5.89B7 Day Performance-0.10%6.57%3.24%0.03%1 Month Performance18.13%25.13%14.95%1.85%1 Year Performance13.67%120.19%66.41%141.10% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 10.23-7.0%N/A+10.7%£4.09M£25K-232.504Gap UpHigh Trading VolumeARCMArc MineralsN/AGBX 1.23+2.1%N/A-30.3%£17.74MN/A-816.6735Gap UpPREMPremier African MineralsN/AGBX 0.02+5.0%N/A-59.5%£17.57MN/A-35.0019Gap UpHigh Trading VolumeCLACelsius ResourcesN/AGBX 0.55flatN/A-14.2%£17.25M£647.00-93.22N/ANews CoveragePOWPower Metal ResourcesN/AGBX 14-1.8%N/A-6.7%£16.19M£526K1,068.7020Positive NewsHigh Trading VolumeKDNCCadence MineralsN/AGBX 4.90+24.1%N/A+71.4%£15.74MN/A-296.796High Trading VolumeTUNTungsten WestN/AGBX 8.20+2.5%N/A+157.9%£15.48MN/A-116.1115LNDLandore ResourcesN/AGBX 3.96+2.7%N/A+23.4%£13.25MN/A-39,550.006Gap UpHigh Trading VolumeBZTBezant ResourcesN/AGBX 0.08+12.9%N/A+206.7%£12.78MN/A-790.005Gap DownHigh Trading VolumeARVArtemis ResourcesN/AGBX 0.43+13.3%N/A-6.7%£12.18M£634.57K-36.64N/AGap DownHigh Trading VolumeCDLCloudbreak DiscoveryN/AGBX 0.86+7.9%N/A+417.1%£12.11MN/A-616.434Gap Up Related Companies and Tools Related Companies Arc Minerals Alternatives Premier African Minerals Alternatives Celsius Resources Alternatives Power Metal Resources Alternatives Cadence Minerals Alternatives Tungsten West Alternatives Landore Resources Alternatives Bezant Resources Alternatives Artemis Resources Alternatives Cloudbreak Discovery Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRTX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
